Oral Immunization with a Live Coxsackievirus/HIV Recombinant Induces Gag p24-Specific T Cell Responses

BACKGROUND: The development of an HIV/AIDS vaccine has proven to be elusive. Because human vaccine trials have not yet demonstrated efficacy, new vaccine strategies are needed for the HIV vaccine pipeline. We have been developing a new HIV vaccine platform using a live enterovirus, coxsackievirus B4...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Rui, Shampang, Anae, Nashar, Toufic, Patil, Manisha, Fuller, Deborah H., Ramsingh, Arlene I.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2932689/
https://www.ncbi.nlm.nih.gov/pubmed/20824074
http://dx.doi.org/10.1371/journal.pone.0012499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2932689/
https://www.ncbi.nlm.nih.gov/pubmed/20824074
http://dx.doi.org/10.1371/journal.pone.0012499

Ejemplares similares